Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011)
Integra Lifesciences Holdings (IART) reported Land & Improvements of $2.7 million for Q4 2011, down 0.62% on a YoY basis from $2.7 million in Q4 2010, and down 0.62% sequentially from $2.7 million in Q4 2010.
Integra Lifesciences Holdings (IART) Land & Improvements (2010 - 2011) Analysis & Trends
Integra Lifesciences Holdings (IART) has 2 years of Land & Improvements data on file, last reported at $2.7 million in Q4 2011.
- For the quarter ending Q4 2011, Land & Improvements fell 0.62% year-over-year to $2.7 million; the trailing twelve-month figure through Dec 2011 stood at $2.7 million (down 0.62% YoY), and the FY2011 full-year result was $2.7 million, down 0.62% from the prior year.
- Land & Improvements slipped to $2.7 million in Q4 2011, from $2.7 million in the prior quarter.
- In the past five years, Land & Improvements ranged from a high of $2.7 million in Q4 2010 to a low of $2.7 million in Q4 2011.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Land & Improvements (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 1.80 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 188.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Integra Lifesciences Holdings | 1.71 Bn | 1.45 Bn | 216.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2011 | 2.71 Mn |
| Dec 31, 2010 | 2.73 Mn |